Skip to main content
News Home

News Archive

BAUS Endorses the Leng Review to Enhance Governance and Patient Safety

Following an independent review into Physician Associate (PA) and Anaesthesia Associate (AA) professionals by Professor Gillian Leng CBE – initially commissioned in November 2024 – the Leng Review was successfully published in July 2025. BAUS... Read more

7 Oct 2025

NICE Approves Use of New Treatment for Advanced Metastatic Bladder Cancer

Enfortumab Vedotin combined with Pembrolizumab will now be available for eligible patients in the UK

The British Association of Urological Surgeons (BAUS) welcomes the decision by the National Institute for Health and Care Excellence (NICE) to approve the use of combination therapy enfortumab vedotin (Padcev) with pembrolizumab as a first-line... Read more

22 Aug 2025